Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs11812896 | chr10:134425271 | G/A | 0.000334 | 171 | 24.7 | 26.62 | 2.23 | KM Plot |
PCPG | rs118129718 | chr10:69581393 | C/T | 0 | 171 | 25.87 | 16.97 | 2.28 | KM Plot |
PCPG | rs118130792 | chr10:69739356 | G/C | 0 | 177 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs118130855 | chr12:56677979 | T/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs118134111 | chr7:105161229 | A/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs11814062 | chr10:134439823 | C/T | 0.00036 | 170 | 24.62 | 26.62 | 2.23 | KM Plot |
PCPG | rs11830312 | chr12:5112406 | C/G | 2.96E-5 | 177 | 25.47 | 24.1 | 14.4 | KM Plot |
PCPG | rs11835979 | chr12:26886812 | C/T | 8.74E-5 | 178 | 24.5 | 27.87 | 5.97 | KM Plot |
PCPG | rs11842958 | chr13:28233801 | A/G | 5.3E-6 | 178 | 25.28 | 26.22 | 11.78 | KM Plot |
PCPG | rs11844548 | chr14:74319455 | G/A | 9.6E-6 | 178 | 25.47 | 28.3 | 10.3 | KM Plot |
PCPG | rs11857970 | chr15:39739456 | A/T | 0.000419 | 178 | 24.85 | 26.47 | 26.33 | KM Plot |
PCPG | rs11859947 | chr16:1767072 | A/C | 1.76E-11 | 173 | 25.67 | 18.75 | 4.52 | KM Plot |
PCPG | rs11862081 | chr16:89588488 | A/G | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |
PCPG | rs11863003 | chr16:1746794 | A/G | 0.000436 | 178 | 25.47 | 19.57 | 6.1 | KM Plot |
PCPG | rs11864726 | chr16:89587030 | C/T | 0.000192 | 177 | 26.78 | 25.4 | 19.53 | KM Plot |